EPISODE · Sep 22, 2022 · 16 MIN
How a once-weekly insulin could disrupt diabetes management
from pharmaphorum Podcast · host pharmaphorum
In the latest pharmaphorum podcast, Florian Baeres, Corporate Vice President for global medical affairs at Novo Nordisk, joins editor in chief Jonah Comstock to talk about the innovative once-weekly insulin currently in development and how it could change the game for people currently managing their type 2 diabetes with daily injections.
Embed this episode
NOW PLAYING
How a once-weekly insulin could disrupt diabetes management
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.